Inventor

VALERIA R. FANTIN

Inventor

Overview

10→

Patents

2021–2026

Patent span

Human necessities

Primary field (CPC A)

Patents· 10 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes27%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%

C07HSugars19%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium14%

C07BGeneral methods of organic chemistry8%

C07JSteroids3%

C07KPeptides3%

PatentTitleYear

12,577,272CD73 inhibitors2026 12,544,391CD73 inhibitors2026 12,454,544CD73 inhibitors2025 12,018,043CD73 inhibitors2024 11,807,658CD73 inhibitors2023 11,576,922CD73 inhibitors2023 11,530,236CD73 inhibitors2022 11,377,469CD73 inhibitors2022 11,325,938CD73 inhibitors2022 11,208,432Inhibitors of glucocorticoid receptor2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2026Patents assigned to ORIC PHARMACEUTICALS INC (10)· patent assignee history

2021–2026Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ORIC PHARMACEUTICALS INC	10	2021–2026

Locations

Location	Patents	Span
US	10	2021–2026